Insights & Discussion
Discover Related Insights
Pomegranate juice consumption appears to somewhat enhance inflammatory status and complete blood count in hospitalized COVID-19 patients.
2023 Complementary Therapies in Medicine Adjuvant pomegranate juice intake improves the inflammatory status of hospitalized COVID-19 patients: A randomized and placebo-controlled trial Yousefi M, Sadriirani M, Mahmoodi S, Samimi B, Pourmahmoudi A, Hosseinikia M, et al.
Randomised Controlled Trial CRP Inflammation
The study was a randomized, double-blinded placebo-controlled trial involving 48 patients and had two parallel arms. As part of their standard hospital care, patients were either given 500 mL of whole pomegranate juice daily or a placebo for a period of 14 days. The researchers focused on measuring inflammatory indicators and complete blood counts both at the start of the study and at the end of the 14-day intervention period.
Following the 14-day intervention, there was a distinguishable decrease in primary outcomes including inflammatory markers such as C reactive protein, interleukin-6, and erythrocyte sedimentation rate in the group that consumed pomegranate juice as compared to the readings before the intervention. In addition, considerable changes were also observed in secondary outcomes such as neutrophils, lymphocytes, platelets, platelets-to-lymphocyte and neutrophils-to-lymphocyte ratios in the pomegranate juice group compared to the parameters before the intervention. Finally, the mean changes in levels of interleukin-6, white blood cells, neutrophils, lymphocyte, platelets, platelets-to-lymphocyte ratio, blood oxygen saturation and MCV were significantly different between the two groups by the end of intervention, while no significant difference was noted in other blood indices.
Acupuncture has shown to be potentially beneficial as an alternate or adjunct therapy for patients with Bell's palsy following recovery from COVID-19.
2022 Journal of Complementary and Alternative Medical Research Can Acupuncture be an Adjunct Therapy for Bell’s palsy Post COVID-19? Acupuncture for Bell’s Palsy: A Review Yepthomi T, Somanadhapai S
Review Article Bell's Palsy
In the methodology utilized for this research, an extensive literature search was carried out by two independent investigators. They used multiple sources including PubMed, MEDLINE, Google scholar, LILACS, and the Cochrane Register of Controlled Trials, from the year 2000 up until 2021. They used the keywords: Bell’s Palsy, covid-19, acupuncture, Mucormycosis, vaccine, and steroids. Selected articles were only those published in English and included full-text. The studies included in the review were all randomized controlled trials which compared acupuncture intervention's clinical effects (used alone or add on) with no treatment.
In terms of results, although the methodological quality of most studies was considered generally low, six randomized controlled trials were found to be satisfactory and included in the study. According to the results across these studies, the groups who received acupuncture treatment reported improved outcomes compared to their baseline or control groups. This was evident as no negative side effects were reported. The review therefore indicates that acupuncture could play a beneficial role in treating patients with Bell's palsy post-recovery from COVID-19, particularly those at risk of mucormycosis and other severe health complications.
The Jing Si Herbal Drink, composed of various antiviral, antioxidant and anti-inflammatory herbs, has been confirmed as potentially effective in treating COVID-19 symptoms.
2022 Pharmacological Research - Modern Chinese Medicine Jing Si Herbal Drink as a prospective adjunctive therapy for COVID-19 treatment: Molecular evidence and mechanisms Lu PH, Tseng CW, Lee JL, Lee EY, Lin YP, Lin IH, et al.
Review Article Ai Ye Anti-Inflammatory Antioxidant
The methodology incorporated in this study involves analyzing the efficacy of the component herbs present in Jing Si Herbal Drink (JSHD). This was done through in vivo and in vitro testing to understand their potential in treating COVID-19. JSHD comprises a combination of 5 antiviral, 7 antioxidant, 7 anti-inflammatory herbs. Furthermore, it includes 2 herbs that inhibit the overactive immune system, one herb that reduces cell apoptosis, and another with antithrombotic ability. These constituent herbs were evaluated for their impact on the pathogenesis of COVID-19.
Discussion of the results showed that the ingredients in JSHD have demonstrated potential effectiveness against COVID-19. The active ingredients in the drink were effective in providing symptomatic relief for infected patients. The antiviral, antioxidant, and anti-inflammatory herbs, along with those altering immune response, inhibiting cellular apoptosis and providing antithrombotic capacity, were all found beneficial against the disease. Thus, JSHD holds promise as a useful adjuvant or supplementary treatment in handling COVID-19.
Pomegranate extract and its phytochemicals can potentially inhibit severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) and improve gut microbiota, preventing obesity and diabetes.
2022 Biomedicine & Pharmacotherapy Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review Maphetu N, Unuofin JO, Masuku NP, Olisah C, Lebelo SL
Review Article Gut Microbiota Obesity Pomegranate
The study employs the use of in silico molecular docking methodologies to demonstrate that extract from pomegranates and their phytochemicals can serve as inhibitors of severe acute respiratory syndrome coronavirus 2's spike protein and the angiotensin-converting enzyme 2 receptor contact. These findings are further reinforced by clinical trials which suggest that pomegranates can also alleviate non-alcoholic fatty liver disease, metabolic syndrome, dental infections, and symptoms of menopause.
This study has also identified numerous active compounds within pomegranates such as alkaloids, anthocyanidins, tannins, flavonoids, phenolics, proanthocyanidins, sterols, terpenes, terpenoids, xanthonoids, fatty acids, organic acids, lignans, saccharides, and vitamin C. This mixture of active compounds is believed to significantly contribute to the broad array of pharmacological activities identified within the pomegranate. This includes anti-diabetic, anti-tumor, anti-inflammatory, anti-malaria, anti-fibrotic, anti-fungal, and anti-bacterial effects. The extract from this fruit improves gut microbiota which could potentially aid in the prevention of obesity and diabetes.
Pomegranate juice, due to its unique bioactive compounds, could potentially alleviate complications related to SARS-CoV-2 infections, especially in patients with pre-existing chronic diseases.
2022 Journal of Nutrition and Metabolism Possible Beneficial Effects of Fresh Pomegranate Juice in SARS-CoV-2 Infection Conditions Banihani SA
Review Article Pomegranate
The methodology employed in this research involved reviewing and discussing currently available published evidence of the beneficial effects of pomegranate juice during conditions of viral infections. The team exploited databases such as PubMed and Scopus to access relevant references. They centered their investigation around the hypothesis that the bioactive compounds in fresh pomegranate juice are advantageous in various chronic diseased conditions, thereby making the juice potentially beneficial for SARS-CoV-2 infected patients.
In the discussion of results, the researchers found compelling evidence supporting the idea that pomegranate juice can be helpful in the contexts of SARS-CoV-2 infections, particularly for those patients who have a clinical history of chronic diseases like hypertension, cardiovascular disease, diabetes, and cancer. Notably, they point out that it is the unique bioactive compounds in the juice that make it beneficial for such situations.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.